Centene Corporation balance sheet
At the end of fiscal 2025, Centene Corporation had total assets of $76.75bn, total liabilities of $56.69bn and shareholders' equity of $19.95bn. It held $17.89bn in cash against $17.49bn of debt: net cash of $395m.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.4 | 0.4 | 0.6 | 0.7 | 1.0 | 1.6 | 1.8 | 3.9 | 4.1 | 5.3 | 12.1 | 10.8 | 13.1 | 12.1 | 17.2 | 14.1 | 17.9 | 20.7 |
| Total current assets | 0.6 | 0.7 | 0.9 | 1.4 | 1.8 | 3.0 | 3.6 | 8.4 | 8.7 | 12.0 | 20.3 | 23.4 | 28.5 | 30.1 | 40.8 | 38.0 | 40.4 | 45.5 |
| Goodwill | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.8 | 0.8 | 4.7 | 4.7 | 7.0 | 6.9 | 18.7 | 19.8 | 18.8 | 17.6 | 17.6 | 10.8 | 10.8 |
| Total assets | 1.7 | 1.9 | 2.2 | 2.8 | 3.5 | 5.8 | 7.3 | 20.2 | 21.9 | 30.9 | 41.0 | 68.7 | 78.4 | 76.9 | 84.6 | 82.4 | 76.7 | 79.3 |
| Deferred revenue (current) | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.7 | 0.7 | 0.7 | 0.7 |
| Total current liabilities | 0.7 | 0.8 | 0.8 | 1.2 | 1.6 | 2.9 | 3.6 | 8.6 | 9.3 | 12.0 | 12.9 | 21.6 | 25.8 | 28.5 | 36.7 | 34.3 | 36.7 | 39.1 |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Long-term debt | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | 0.9 | 1.2 | 4.7 | 4.7 | 6.6 | 13.6 | 16.7 | 18.6 | 17.9 | 17.7 | 18.4 | 17.4 | 15.5 |
| Total debt | 0.3 | 0.3 | 0.4 | 0.5 | 0.7 | 0.9 | 1.2 | 4.8 | 4.8 | 6.9 | 13.9 | 16.9 | 19.0 | 18.2 | 18.0 | 18.6 | 17.5 | 15.5 |
| Total liabilities | 1.1 | 1.1 | 1.3 | 1.8 | 2.3 | 3.9 | 5.0 | 14.1 | 15.0 | 19.9 | 28.3 | 42.8 | 51.4 | 52.6 | 58.7 | 55.9 | 56.7 | 57.0 |
| Shareholders' equity | 0.6 | 0.8 | 0.9 | 1.0 | 1.2 | 1.7 | 2.2 | 5.9 | 6.9 | 10.9 | 12.6 | 25.8 | 26.8 | 24.1 | 25.8 | 26.4 | 20.0 | 22.2 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | 0.1 | 0.2 | — | — | — | — | — | — | — | — | — | — | — |
| Net debt (negative = net cash) | −0.1 | −0.1 | −0.2 | −0.2 | −0.3 | −0.7 | −0.5 | 0.9 | 0.8 | 1.5 | 1.7 | 6.1 | 5.9 | 6.1 | 0.8 | 4.6 | −0.4 | −5.2 |
| Shares outstanding | 173m | 198m | 203m | 209m | 221m | 237m | 241m | 344m | 347m | 412m | 415m | 581m | 582m | 551m | 534m | 496m | 492m | 495m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 38.0 | 41.3 | 40.4 | 44.1 | 40.4 | 45.0 | 46.7 | 45.5 |
| Goodwill | 17.6 | 17.6 | 17.6 | 10.8 | 10.8 | 10.8 | 10.8 | 10.8 |
| Total assets | 82.4 | 87.0 | 86.4 | 82.1 | 76.7 | 81.2 | 83.0 | 79.3 |
| Deferred revenue (current) | 0.7 | 0.9 | 0.7 | 0.7 | 0.7 | 1.0 | 0.7 | 0.7 |
| Total current liabilities | 34.3 | 37.1 | 36.8 | 40.6 | 36.7 | 40.0 | 40.8 | 39.1 |
| Short-term debt | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Long-term debt | 18.4 | 18.3 | 17.6 | 17.5 | 17.4 | 16.3 | 16.0 | 15.5 |
| Total debt | 18.5 | 18.3 | 17.6 | 17.6 | 17.4 | 16.4 | 16.1 | 15.5 |
| Total liabilities | 55.9 | 59.0 | 58.9 | 61.0 | 56.7 | 59.6 | 60.4 | 57.0 |
| Shareholders' equity | 26.4 | 27.9 | 27.4 | 20.9 | 20.0 | 21.4 | 22.6 | 22.2 |
| Shares outstanding | 496m | 498m | 491m | 491m | 492m | 494m | 494m | 495m |
Compare with peers
- Elevance Health balance sheet
- Humana balance sheet
- UnitedHealth Group balance sheet
- Molina Healthcare, Inc. balance sheet
- Oscar Health, Inc. balance sheet
Head to head: CNC vs ELVCNC vs HUMCNC vs UNH
More: Managed Health Care stocks compared, Health Care sector, rankings of US companies